Journal of Clinical Investigation · 1989 · 79 citations · 30 references
Life SciencesImmunologyPathobiologyAdaptive ImmunityCellular ImmunologyClinical ImmunologyAdaptive Immune ResponsesCellular Immunity In InfectionImmune FunctionImmunodeficiency DisordersLymphocyte ActivationViral PathogenesisAntigen-induced Lymphocyte ProliferationEscherichia ColiHiv Envelope Glycoprotein AntigensLymphocyte Proliferation InhibitionT-cell Immune ResponsesT-cell Mediated Responses
All HIV seronegative (HIV Ab-) and most HIV seropositive (HIV Ab+) individuals' lymphocytes failed to proliferate in primary cultures in response to purified HIV or to recombinant envelope and core antigens of HIV, even in the presence of recombinant interleukin 2 (rIL-2). Most HIV Ab- and HIV Ab+ individuals' lymphocytes, however, could proliferate or be induced by rIL-2 to proliferate in response to lysates of Escherichia coli or Saccharomyces cerevisiae. These findings indicate selective defects in lymphocyte proliferative responses to HIV antigens before the development of AIDS in which lymphocytes are unable to proliferate in response to any antigens. These defects in cell-mediated immune responses to HIV antigens are likely to play an important role in the pathobiology of HIV infections. Although intact HIV or glycosylated gp120 envelope protein of HIV are involved in these defects, a non-glycosylated recombinant form of the HIV gp120 envelope (ENV2-3) and p25 core proteins did not inhibit antigen- or mitogen-driven lymphocyte proliferation.
30
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS
Jay A. Levy, Anthony Hoffman, Susan M. Kramer et al. · Science · 1984 · 1.4K citations
HIV-specific cytotoxic T lymphocytes in seropositive individuals
Bruce D. Walker, Sekhar Chakrabarti, Bernard Moss et al. · Nature · 1987 · 783 citations
Cytotoxic T Cells in Cytomegalovirus Infection
Gerald V. Quinnan, Alain H. Rook, Jody Manischewitz et al. · New England Journal of Medicine · 1982 · 596 citations